TONIX PHARMACEUTICALS HOLDING CORP. Stock Split Ratio
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Stock Split Ratio of 10.00% for the 0-month period ending 2019-11-01, per its 10-K filed 2020-03-24.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-03-24
- TONIX PHARMACEUTICALS HOLDING CORP. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|
| 2019-11-01 | 10.00% 10-K · filed 2020-03-24 | |
| 2018-12-31 | 10.00% 10-K · filed 2019-03-18 | |
| 2018-11-28 | 10.00% 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |